Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01178385

Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders

Sponsor: University of South Florida

Conditions Asperger's Syndrome Autism Generalized Anxiety Disorder Obsessive-compulsive Disorder Separation Anxiety Disorder Social Phobia

Interventions Cognitive-behavioral therapy Treatment as Usual

Updated 9 times since 2017 Last updated: Feb 25, 2013 Started: Apr 30, 2010 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Asperger's Syndrome and Autism and is currently completed. University of South Florida leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2_PHASE3
Nov 2020 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

▶ Show 4 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed PHASE2_PHASE3
May 2018 — Jun 2018 [monthly]

Completed PHASE2_PHASE3
Aug 2017 — May 2018 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Aug 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of South Florida

Data source: University of South Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• St. Petersburg, United States